Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial

Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin

(2016) Satoru Tamaoki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Evidence-based clinical practice guidelines for liver cirrhosis 2015

(2016) Hiroshi Fukui et al.   JOURNAL OF GASTROENTEROLOGY

Cirrhosis and dysbiosis: New insights from next-generation sequencing

(2015) James Gorham et al.   HEPATOLOGY

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications

(2015) Francesca Romana Ponziani   WORLD JOURNAL OF GASTROENTEROLOGY

Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy

(2014) N. Kimer et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Classification of the etiologies of acute liver failure in Japan: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan

(2014) Satoshi Mochida et al.   HEPATOLOGY RESEARCH

Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations

(2014) E.A. Debbia et al.   JOURNAL OF CHEMOTHERAPY

Gut microbiota and liver disease

(2014) Amit Goel et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites

(2014) Philipp Lutz et al.   PLoS One

Acetyl-L-carnitine in hepatic encephalopathy

(2013) Michele Malaguarnera   METABOLIC BRAIN DISEASE

Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis

(2013) Dong Wu et al.   Gastroenterology Research and Practice

Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma

(2012) Kazuyuki Suzuki et al.   HEPATOLOGY RESEARCH

The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis

(2012) Mohamad A. Hanouneh et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Techniques used to characterize the gut microbiota: a guide for the clinician

(2012) Marianne H. Fraher et al.   Nature Reviews Gastroenterology & Hepatology

Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

(2011) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Linkage of gut microbiome with cognition in hepatic encephalopathy

(2011) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

(2010) Sandeep Singh Sidhu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

(2010) Jasmohan S. Bajaj et al.   GASTROENTEROLOGY

Gut Flora and Hepatic Encephalopathy in Patients with Cirrhosis

(2010) Stephen M. Riordan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is Oral l-Acyl-Carnitine an Effective Therapy for Hepatic Encephalopathy? Review of the Literature

(2008) Nathan J. Shores et al.   DIGESTIVE DISEASES AND SCIENCES

Gut ammonia production and its modulation

(2008) Manuel Romero-Gómez et al.   METABOLIC BRAIN DISEASE